Hepatic colorectal metastasis: Current status of surgical therapy Journal Article


Authors: Fong, Y.; Blumgart, L. H.
Article Title: Hepatic colorectal metastasis: Current status of surgical therapy
Abstract: Metastatic colorectal cancer to the liver develops in over 50,000 US patients each year and is rapidly fatal if untreated. Even the most active chemotherapeutic agents rarely prolong survival for more than 3 years. Liver resection is the only potentially curative treatment, affording 5-year survival in one-third of patients. The only absolute contraindications to liver resection are poor general health, clear evidence of wide disease dissemination, or inability to resect all liver disease. Close follow-up is warranted after liver resection since disease recurs in two-thirds of patients and recurrences can be successfully treated, possibly with curative potential. Cryosurgery is a promising ablative modality that needs to be compared to chemotherapy but has not been proven to be curative.
Keywords: clinical trial; review; patient selection; liver neoplasms; chemotherapy, adjuvant; metastasis; pathology; colorectal neoplasms; colorectal tumor; adjuvant chemotherapy; liver tumor; clinical trials; cryosurgery; humans; prognosis; human
Journal Title: Oncology (Norwalk)
Volume: 12
Issue: 10
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 1998-10-01
Start Page: 1489
End Page: 1498
Language: English
PUBMED: 9798202
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. Leslie H Blumgart
    352 Blumgart
  2. Yuman Fong
    775 Fong